Cantargia publishes full year report for 2022 (Información remitida por la empresa firmante) LUND, Sweden, Feb. 23, 2023 /PRNewswire/ -- Cantargia AB's ("Cantargia") full year report for 2022 is now available on the company's web page www.
Cantargia advances TRIFOUR trial to randomized stage following promising early safety and efficacy of nadunolimab in tri
Cantargia advances TRIFOUR trial to randomized stage following promising early safety and efficacy of nadunolimab in tri
Gerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels
